Q1 2026 · 1 tracked holders Data updated 17 Nov 2026 · SEC filings

DENALI THERAPEUTICS INC

DENALI THERAPEUTICS INC

Ownership in Q1 2026 · CUSIP 24823R105

Investors holding this security
1
In available Q1 2026 reports
Combined reported value
$1.25M
Across tracked holders
New holders this quarter
1
Compared with the prior reported quarter

An ownership snapshot from SEC filings. Portfolio % measures each investor's exposure, not their share of the company.

Investors & position changes

Investor Portfolio % Change Shares change Reported value Shares Price after filing Return since filing
Polen Capital Management Disclosed 14 May 2026 0.01% New New $1.25M 65K — —

Reported holdings can change before they become public. The optional return figures measure price change after disclosure, not an investor's actual profit. Price coverage and filing dates differ.

Number of holders
Combined reported value